EtoGesic Tablets are indicated for the control of pain and inflammation associated with osteoarthritis in dogs. EtoGesic is a non-narcotic, non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, antipruretic, and analgesic activity medication. EtoGesic relieves joint stiffness and helps arthritic dogs overcome the pain and discomfort of painful joints.
Non-steroidal anti-inflammatory drugs (NSAID) reduce hormones that cause inflammation and pain in the body.
Generic Name: Etodolac
DOSAGE AND ADMINISTRATION
The recommended dose of ETOGESIC Tablets is 4.5 to 6.8 mg/lb body weight (10 to 15 mg/kg) administered once daily. Due to tablet sizes and scoring, dogs weighing less than 11 lb (5 kg) cannot be accurately dosed. The effective dose and duration should be based on clinical judgment of disease condition and patient tolerance of drug treatment. The initial dose level should be adjusted until a satisfactory clinical response is obtained, but should not exceed 15 mg/kg once daily.
Use the lowest effective dose for the shortest duration consistent with individual treatment response.
Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian.
CONTRAINDICATIONS
EtoGesic Tablets are contraindicated in animals previously found to be hypersensitive to etodolac.
WARNINGS
Not for human use. Keep out of reach of children. Consult a physician in cases of accidental ingestion by humans. Do not use in cats. For use in dogs only.
Adverse Reactions:
Adverse reactions with Etogesic Tablets, as with other non-steroidal anti-inflammatory drugs, may occur and include: decreased appetite, vomiting, diarrhea, dark or tarry stools, increased water consumption, increased urination, pale gums due to anemia, yellowing of gums, skin or white of the eye due to jaundice, lethargy, incoordination, seizure, or behavioral changes.
Additional information not available for this medicine.